Association between 25-hydroxyvitamin D and interleukin 17 levels in severe obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
The association between obstructive sleep apnea syndrome and vitamin D deficiency Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders Year: 2016
Relationship between obstructive sleep apnea syndrome, plasma homocysteine levels and cardiovascular risk Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
The positive effect of CPAP therapy on the level of liver enzymes in obstructive sleep apnea patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Serum YKL-40 level is associated with apnea hypopnea index in patients with obstructive sleep apnea syndrome Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014
The concentration and expression of L-selectin in normoglycemic obstructive sleep apnea patients Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Serum midkine levels in patients with obstructive sleep apnea Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
Can we use the oxygen desaturation index alone to reliably diagnose obstructive sleep apnoea in obese patients? Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea Year: 2016
C reactive protein and obstructive sleep apnea in obese patients Source: International Congress 2014 – Sleep disordered breathing 1 Year: 2014
Serum omentin levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Serum levels of adipokines in obstructive sleep apnea Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults Year: 2015
Evaluation of variables related with sympathetic activity in obstructive sleep apnea patients with and without excessive daytime sleepiness Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA) Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Year: 2015
Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Long term changes of C-rective protein (CRP) in obstructive sleep apnoea (OSA) with or without treatment Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Daytime sleepiness in patients with obstructive sleep apnoea syndrome and its correlation to insulin resistance Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016
A simple device to subject cells to intermittent hypoxia mimicking obstructive sleep apnea Source: Annual Congress 2013 –COPD: experimental biology Year: 2013